Blockchain Registration Transaction Record

Formycon and OneSource Join Forces for Biosimilar Manufacturing

Formycon and OneSource announce strategic manufacturing partnership for biosimilars, combining development and manufacturing to expand global access to affordable biologics.

This partnership matters because it strengthens the global supply chain for affordable biosimilars, which are critical for treating serious and chronic diseases. By combining Formycon's development prowess with OneSource's cost-efficient manufacturing in India, the collaboration aims to reduce healthcare costs and expand patient access to life-changing therapies worldwide, especially as patents on major biologics expire in the coming years.